LUCIA LEITE-LAIS

Prof. Dr. LUCIA LEITE-LAIS

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2021 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
Lucia  PedrosaLucia Pedrosa
Lucia Pedrosa
ABAcsa N.A.B. Barros
Acsa N.A.B. Barros
LUCIA LEITE-LAISLUCIA LEITE-LAIS
LUCIA LEITE-LAIS

29 January 2022 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
TCThais Cunha
Thais Cunha
KVKarina M. Vermeulen-Serpa
Karina M. Vermeulen-Serpa
EGEvellyn C. Grilo
Evellyn C. Grilo
LUCIA LEITE-LAISLUCIA LEITE-LAIS
LUCIA LEITE-LAIS
JBJosé Brandao-Neto
José Brandao-Neto
SVSancha Helena de Lima Vale
Sancha Helena de Lima Vale

19 July 2018 in Journal of Nutrition and Metabolism
Verified
Journal Article
Open access
ABAcsa Nara A. B. Barros
Acsa Nara A. B. Barros
MDMário Emílio T. Dourado
Mário Emílio T. Dourado
LPLucia de Fatima C. Pedrosa
Lucia de Fatima C. Pedrosa
LUCIA LEITE-LAISLUCIA LEITE-LAIS
LUCIA LEITE-LAIS
Oxidative stress is one of the main mechanisms associated with the pathogenesis of amyotrophic lateral sclerosis (ALS). Copper can affect cellular oxidation and lipid metabolism. The aim of this study was to evaluate the association of copper status with lipid profile and functional status in patients with ALS. A cross-sectional study was carried out including 27 patients with ALS (case group) and 26 healthy individuals (control group). Copper status was evaluated by habitual dietary copper intake, plasma copper, and serum ceruloplasmin concentrations. The lipid profile included analysis of serum total cholesterol (TC), LDL-cholesterol (LDL-c), HDL-cholesterol (HDL-c), and triglycerides (TGL). The functional status of patients with ALS was assessed by the ALS Functional Rating Scale-Revised (ALSFRS-R). In the case group, plasma copper was lower compared with the control group (133.9 versus 164.1 μg/dL,p=0.0001) and was positively correlated with HDL-c (rs=0.398,p=0.044). In the control group, plasma copper was positively correlated with serum ceruloplasmin (rs=0.646,p<0.001), TC (rs=0.446,p=0.025), LDL-c (rs=0.445,p=0.029), and HDL-c (rs=0.479,p=0.015), and serum ceruloplasmin was positively correlated only with LDL-c (rs=0.407,p=0.043). In the case group, dietary copper intake (B=−0.373,p<0.001), plasma copper (B=−0.005,p=0.033), and TC (B=−0.312,p=0.001) were inversely associated with the functional status of patients with ALS. In contrast, serum ceruloplasmin (B=0.016,p=0.044), LDL-c (B=0.314,p=0.001), HDL-c (B=0.308,p=0.001), and TGL (B=0.062;p=0.001) were positively associated with their functional status. In conclusion, this study suggests a disturbance of copper status and its connection with the lipid profile in patients with ALS. Furthermore, copper status and lipid profile may influence the functional status of patients with ALS, standing out as potential biomarkers of disease severity.

23 February 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MDMychelle Kytchia Rodrigues Nunes Duarte
Mychelle Kytchia Rodrigues Nunes Duarte
LUCIA LEITE-LAISLUCIA LEITE-LAIS
LUCIA LEITE-LAIS
ALAgnez-Lima Fassarella Lucymara
Agnez-Lima Fassarella Lucymara
BMBruna Maciel
Bruna Maciel
AMAna Morais
Ana Morais
Background: Obesity results from interactions between environmental factors, lifestyle, and genetics. In this scenario, nutritional genomics and nutrigenetic tests stand out, with the promise of helping patients avoid or treat obesity. This narrative review investigates whether nutrigenetic tests may help to prevent or treat obesity. Scientific studies in PubMed Science Direct were reviewed, focusing on using nutrigenetic tests in obesity. The work showed that few studies address the use of tools in obesity. However, most of the studies listed reported their beneficial effects in weight loss. Ethical conflicts were also discussed, as in most countries, there are no regulations to standardize these tools, and there needs to be more scientific knowledge for health professionals who interpret them. International Societies, such as the Academy of Nutrition and Dietetics and the Brazilian Association for the Study of Obesity and Metabolic Syndrome, do not recommend nutrigenetic tests to prevent or treat obesity, especially in isolation. Advancing nutrigenetics depends on strengthening three pillars: regulation between countries, scientific evidence with clinical validity, and professional training.

29 November 2016 in Nutrición Hospitalaria
Verified
Journal Article
Open access
KVKarina Marques Vermeulen
Karina Marques Vermeulen
LLLeilane Lilian Araújo Leal
Leilane Lilian Araújo Leal
MFMariana Câmara Martins Bezerra Furtado
Mariana Câmara Martins Bezerra Furtado
SVSancha Helena de Lima Vale
Sancha Helena de Lima Vale
LUCIA LEITE-LAISLUCIA LEITE-LAIS
LUCIA LEITE-LAIS
Assessing severity and nutritional prognosis in critical patients has become increasingly important in recent years, since these parameters are related to morbidity/mortality and used to guide therapeutic options. Determine nutritional prognosis through the Phase Angle (PA) and Onodera's Prognostic Nutritional Index (OPNI) and its relationship with severity, hospitalization time and mortality of critically ill patients. Descriptive cross-sectional study, involving adult patients hospitalized in an Intensive Care Unit (ICU). Data were collected from the patients' medical records to calculate severity indicators (APACHE II, SOFA and SAPS 3) and determine the length of hospitalization and outcome. Bioimpedance was conducted to calculate the PA, using resistance and reactance data. A total of 35 patients (26% men and 74% women), with mean age of 55.5 ± 16.7 years, were included. The mortality rate (17%) was similar to that expected by APACHE II and SOFA, but higher than that predicted by SAPS 3. The mean values for the PA (4.2 ± 1.0) and OPNI (38.7 ± 8.3) were lower than the reference values adopted. Individuals with PA < 5.1 exhibited significantly lower reactance and albumin and higher APACHE II and SOFA values, in addition to longer hospitalization time and higher mortality. The PA was inversely correlated with all the severity indicators under study (APACHE II, SOFA and SAPS 3), and the length of hospitalization. By contrast, there was no correlation between OPNI and these parameters, or between PA and OPNI. The PA proved to be a good tool in assessing nutritional prognosis in critically ill patients. By contrast, more studies using the OPNI with this type of patients are needed.

28 May 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
KVKarina M. Vermeulen
Karina M. Vermeulen
MLMárcia Marília G. D. Lopes
Márcia Marília G. D. Lopes
CACamila X. Alves
Camila X. Alves
NBNaira J. N. Brito
Naira J. N. Brito
Maria Graças AlmeidaMaria Graças Almeida
Maria Graças Almeida
JBJosé Brandao-Neto
José Brandao-Neto
The parameters derived from bioelectrical impedance, phase angle (PA) and bioelectrical impedance vector analysis (BIVA) have been associated with cell membrane integrity and body cell mass. Zinc is a micronutrient that exerts important structural functions and acts in maintaining cellular functionality. To evaluate cell integrity and body cell mass, PA and BIVA were evaluated in children orally supplemented with zinc at different concentrations. Anthropometric, bioelectrical (resistance and reactance) and serum zinc variables were collected from two randomized, triple-blind, controlled clinical trials. Sampling was composed of 71 children consisting of three groups: a control group who received a placebo and two experimental groups who received oral supplementation of 5 or 10 mg-Zn/day for three months. The three groups presented increases (p < 0.001) in the linear height and weight. In the group supplemented with 10 mg-Zn/day, there was an increase in reactance values (p = 0.036) and PA (p = 0.002), in addition to vector displacement (p < 0.001) in relation to the confidence ellipses. An increase in serum zinc concentration was found (p < 0.001) in all three groups. Whit this, the supplementation with 10 mg-Zn/day promotes changes in the integrity of the cell membrane associated with the increase in the cellular mass of healthy children.